Article thumbnail

Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial

By Tapani Ruutu, Liisa Volin, Dietrich W. Beelen, Rudolf Trenschel, Juergen Finke, Marc Schnitzler, Jerzy Holowiecki, Sebastian Giebel, Miroslaw Markiewicz, Lutz Uharek, Igor W. Blau, Joachim Kienast, Matthias Stelljes, Kajsa Larsson, Axel R. Zander, Martin Gramatzki, Roland Repp, Hermann Einsele, Gernot Stuhler, Joachim Baumgart, Heidrun A. Mylius, Uwe Pichlmeier, Mathias Freund and Jochen Casper
Topics: Original Articles
Publisher: Ferrata Storti Foundation
OAI identifier: oai:pubmedcentral.nih.gov:3166105
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles